Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Sierra Oncology Inc (SRRA)

1.82 +0.02 (+1.11%)

10/17/2017  4:00pm

Open:

1.78

Pre. Close:

1.80

High:

1.85

Low:

1.77

Volume:

202,925

Market Cap:

95.13M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-10-17 4:43:14 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 2.27     One year: 2.65

Support:

Support1: 1.64    Support2: 1.46

Resistance:

Resistance1: 1.94    Resistance2: 2.27

Pivot:

1.73

Moving Averages:

MA(5): 1.76     MA(20): 1.69

MA(100): 1.43     MA(250): 1.43

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.06

%K %D:

%K(14,3): 64.23     %D(3): 56.94

RSI:

RSI(14): 62.96

52-Week:

High: 1.94  Low: 1.10  Change(%): 3.4

Average Vol(K):

3-Month: 28037  10-Days 27322

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SRRA has closed below upper band by 32.3%. Bollinger Bands are 158.8% wider than normal. The large width of the bands suggest high volatility as compared to SRRA's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Mon, 16 Oct 2017 17:03:42 GMT
Sierra Oncology to Report Chk1 Inhibitor SRA737 Preclinical Data at AACR-NCI ...

Mon, 17 Jul 2017 17:37:30 GMT
Revisiting The ProNAi/Sierra Oncology Thesis 1 Year Later: Still Not Dead In ...

Wed, 20 Sep 2017 10:52:30 GMT
Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare ...

Mon, 09 Jan 2017 12:00:00 GMT
ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs

Mon, 05 Jun 2017 11:37:30 GMT
Sierra Oncology shares jump 7.3% premarket on news of positive early-stage ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

29.64

% Held by Insiders

1.91

% Held by Institutions

55.72

Shares Short (K)

731

Shares Short Prior Month (K)

647

Stock Financials

EPS

-1.180

EPS Est. Current Year

-0.900

EPS Est. Next Year

-0.810

EPS Est. Next Quarter

-0.230

Forward EPS

-0.812

Book Value (p.s.)

2.150

PEG Ratio

-0.03

Profit Margin

Operating Margin

Return on Assets (ttm)

-17.7

Return on Equity (ttm)

-38.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.671

Qtrly Earnings Growth

Operating Cash Flow (M)

-41.29

Levered Free Cash Flow (M)

-17.47

FoxReading.com

Valuation

P/E

-1.54

P/E Growth Ratio

0.01

P/BV

0.85

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.